Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy
Alexandra C. Apple, M. Schroeder, Anthony J. Ryals, et al.
NeuroImage Clinical (2018) Vol. 20, pp. 110-118
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Gut Microbiota-Derived Short-Chain Fatty Acids: Impact on Cancer Treatment Response and Toxicities
Ghanyah Al-Qadami, Kate R. Secombe, Courtney B. Subramaniam, et al.
Microorganisms (2022) Vol. 10, Iss. 10, pp. 2048-2048
Open Access | Times Cited: 80
Long-Term Fatigue and Cognitive Disorders in Breast Cancer Survivors
Florence Joly, Marie Lange, Mélanie Dos Santos, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1896-1896
Open Access | Times Cited: 108
Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx
Lynne I. Wagner, Robert J. Gray, Joseph A. Sparano, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 17, pp. 1875-1886
Open Access | Times Cited: 82
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group
Ashley M. Henneghan, Kathleen Van Dyk, Tara Kaufmann, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 12, pp. 1625-1633
Open Access | Times Cited: 76
Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review
Longqin Lv, Shanping Mao, Huimin Dong, et al.
Journal of Oncology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 54
<p>Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator</p>
Li Chen, Xiangyi Kong, Zhongzhao Wang, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 1543-1567
Open Access | Times Cited: 51
Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment
Erin M. Gibson, Michelle Monje
Current Opinion in Oncology (2019) Vol. 31, Iss. 6, pp. 531-539
Open Access | Times Cited: 45
The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment
Courtney B. Subramaniam, Joanne M. Bowen, Marc A. Gladman, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 116, pp. 470-479
Open Access | Times Cited: 40
A narrative review of risk factors and interventions for cancer- related cognitive impairment
Lu Bai, Enyan Yu
Annals of Translational Medicine (2021) Vol. 9, Iss. 1, pp. 72-72
Open Access | Times Cited: 36
Altered Brain Functional Networks in Patients With Breast Cancer After Different Cycles of Neoadjuvant Chemotherapy
Jing Yang, Yongchun Deng, Daihong Liu, et al.
Journal of Magnetic Resonance Imaging (2025)
Closed Access
Neurobiological mechanisms underlying sex-related differences in stress-related disorders: Effects of neuroactive steroids on the hippocampus
Katharina M. Hillerer, David A. Slattery, Belinda Pletzer
Frontiers in Neuroendocrinology (2019) Vol. 55, pp. 100796-100796
Open Access | Times Cited: 40
Functional connectome biotypes of chemotherapy-related cognitive impairment
Shelli R. Kesler, Melissa Petersen, Vikram Rao, et al.
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 483-493
Open Access | Times Cited: 37
Neurological Complications of Conventional and Novel Anticancer Treatments
Paola Alberti, Alessandro Salvalaggio, Andreas A. Argyriou, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6088-6088
Open Access | Times Cited: 21
Changes in chemotherapy-induced cognitive impairment in gastrointestinal cancer survivors using multidomain assessments: a prospective cohort study
Kazuya Saita, Kazuaki Tanabe, Yoichi Hamai, et al.
Journal of Cancer Survivorship (2025)
Open Access
Changes of perioperative cognitive function and its effect on quality of life in laryngeal cancer
Zehui Gao, Lina Jia, John Yao, et al.
Perioperative Medicine (2025) Vol. 14, Iss. 1
Open Access
Relationship of fatigue with cognitive performance in women with early‐stage breast cancer over 2 years
Joseph M. Gullett, Ronald A. Cohen, Gee Su Yang, et al.
Psycho-Oncology (2019) Vol. 28, Iss. 5, pp. 997-1003
Open Access | Times Cited: 33
Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways
Kate Oppegaard, Carolyn Harris, Joosun Shin, et al.
Cytokine (2021) Vol. 148, pp. 155653-155653
Open Access | Times Cited: 24
Chemo-brain: An activation likelihood estimation meta-analysis of functional magnetic resonance imaging studies
Lori J. Bernstein, Kim Edelstein, Alisha Sharma, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 130, pp. 314-325
Closed Access | Times Cited: 24
Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysis
Yifei Ma, Nianqi Liu, Yanqi Wang, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101987-101987
Open Access | Times Cited: 10
Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
Zhimeng Yao, Hongmei Dong, Jianlin Zhu, et al.
JCI Insight (2023) Vol. 8, Iss. 14
Open Access | Times Cited: 10
Fibre-rich diet attenuates chemotherapy-related neuroinflammation in mice
Courtney Cross, Maya R. Davies, Emma Bateman, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 13-25
Open Access | Times Cited: 9
Effectiveness of a Computerized Home-Based Cognitive Stimulation Program for Treating Cancer-Related Cognitive Impairment
Jose L. Tapia, María Teresa Taberner-Bonastre, David Collado-Martínez, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 6, pp. 4953-4953
Open Access | Times Cited: 8
Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting‐state fMRI
Senbang Yao, Qinqin Zhu, Qianqian Zhang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 15, pp. 16231-16242
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top